Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02240251 · ClinicalTrials.gov registry record

Excimer Laser Assisted IVC Filter Retrieval

A clinical trial, sponsored by Northwestern University.

Completed
Registry status
535
Enrollment target

NCT02240251: Completed study, sponsored by Northwestern University.

NCT02240251 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 535 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02240251 has completed, sponsored by Northwestern University.

COMPLETED
Registry status
535 participants
Enrollment target

Study Summary

This is a prospective chart review to follow our laser-assisted IVC filter retrieval patients. We intend to validate existing literature and scientific findings by publishing our own clinical experience in difficult IVC filter retrievals.

Primary Outcome

The number and severity of adverse events will be recorded to evaluate safety. This will be conducted as a phone call to the patient 1 week after IVC filter removal and then as a chart review only.

Interventions

  • OTHER Prospective Chart Review

Trial Details

FieldValue
Enrollment Target 535 participants
Start Date 2012-01-03
Est. Completion 2022-11-11
Northwestern University

1,209 total trials

What the finished NCT02240251 record still lists

NCT02240251 is an observational study that tracks outcomes without assigning an intervention. The registered 535 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Prospective Chart Review is the first listed.

NCT02240251 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02240251 about?

NCT02240251 is a clinical study titled "Excimer Laser Assisted IVC Filter Retrieval". This is a prospective chart review to follow our laser-assisted IVC filter retrieval patients. We intend to validate existing literature and scientific findings by publishing our own clinical experience in difficult IVC filter retrievals.

What is the current status of trial NCT02240251?

This trial is currently completed. The enrollment target is 535 participants. The study started on 2012-01-03. Estimated completion is 2022-11-11.

What interventions are being tested in trial NCT02240251?

The interventions under investigation include: Prospective Chart Review (OTHER).

Who is sponsoring clinical trial NCT02240251?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05614739 · 535 participants · Phase 1

    FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

  • NCT07091617 · 535 participants · NA

    Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

  • NCT04910685 · 534 participants · Phase 2

    (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

  • NCT06128551 · 534 participants · Phase 1

    Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02240251, the US trial registry maintained by the National Library of Medicine. NCT02240251 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.